|
complicate and confuse diagnosis. Usually the breathlessness idiopathic pulmonary fibrosis first appears during exercise. The condition may progress to the point where any exertion is impossible. A dry cough is a common symptom. The fingertips may enlarge at the ends and take on a bulbous appearance. This is often referred to as "clubbing". How is pulmonary fibrosis diagnosed? A chest x-ray may give some clues. Pulmonary function tests, which reveal the efficiency of a patient's breathing mechanism, may give other indications. Bronchoalveolar lavage (a test which permits removal and examination of cells in the lower respiratory tract) is sometimes used for diagnosis. Another diagnostic technique involves injection with gallium 67, a substance which is absorbed by inflamed areas that can be seen later on sensitized film. At some point, a lung biopsy may be performed so that cells in and around the alveoli can be examined. Back to Top What is the treatment for pulmonary fibrosis? If one
idiopathic pulmonary fibrosis Brosing alveolitis idiopathic pulmonary fibrosis, Hamman-Rich syndrome idiopathic pulmonary fibrosis, collagen-vascular disease idiopathic pulmonary fibrosis, collagen vascular disease idiopathic pulmonary fibrosis, alveolar injuries idiopathic pulmonary fibrosis, alveolar injury idiopathic pulmonary fibrosis, inflammation of the lung parenchyma idiopathic pulmonary fibrosis, fibrosis of the lung parenchyma idiopathic pulmonary fibrosis, Ebstein-Barr virus idiopathic pulmonary fibrosis, chronic aspiration secondary to gastroesophageal reflux AUTHOR INFORMATION Section 1 of 10 Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography Author: Rajesh G Patel idiopathic pulmonary fibrosis, MD idiopathic pulmonary fibrosis, Director of Medical Intensive and Cardiac Care Units idiopathic pulmonary fibrosis, GV (Sonny) Montgomery VAMC; Assistant Professor idiopathic pulmonary fibrosis, Department of Medicine idiopathic pulmonary fibrosis, Jackson Pulmonary Associates Rajesh G Patel idiopathic pulmonary fibrosis, MD idiopathic pulmonary fibrosis, is a member of the following medical societies: American Association of Bronchology idiopathic pulmonary fibrosis, American College of Chest Physicians idiopathic pulmonary fibrosis, and Editor(s): Stephen P Peters MD idiopathic pulmonary fibrosis, PhD idiopathic pulmonary fibrosis, Professor idiopathic pulmonary fibrosis, Department of Medicine idiopathic pulmonary fibrosis, Wake Forest University; Francisco Talavera idiopathic pulmonary fibrosis, PharmD idiopathic pulmonary fibrosis, PhD idiopathic pulmonary fibrosis, Senior Pharmacy Editor idiopathic pulmonary fibrosis, eMedicine; Daniel R Ouellette idiopathic pulmonary fibrosis, MD idiopathic pulmonary fibrosis, Consultant to the US Army Surgeon General; idiopathic pulmonary fibrosis.
idiopathic pulmonary fibrosis Athic Pulmonary Fibrosis Complications of Idiopathic Pulmonary Fibrosis Misdiagnosis of Idiopathic Pulmonary Fibrosis Undiagnosed Idiopathic Pulmonary Fibrosis Treatments for Idiopathic Pulmonary Fibrosis Doctors and Medical Specialists for Idiopathic Pulmonary Fibrosis Deaths from Idiopathic Pulmonary Fibrosis Medical News Summaries About Idiopathic Pulmonary Fibrosis Books about Idiopathic Pulmonary Fibrosis Articles about Idiopathic Pulmonary Fibrosis Glossary for Idiopathic Pulmonary Fibrosis Surveys relating to Idiopathic Pulmonary Fibrosis Discussion forum about Idiopathic Pulmonary Fibrosis Diseases > Idiopathic Pulmonary Fibrosis > Introduction Did we miss something? Please provide feedback or suggestions. By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating an.
idiopathic pulmonary fibrosis The dose may have to be adjusted so that the medicine gives the best possible results with the least side effects. Most side effects are reduced when the dose is made smaller or the drug is stopped. Commonly used drugs are prednisone and cytoxan. Oxygen administration and idiopathic pulmonary fibrosis, in special cases idiopathic pulmonary fibrosis, transplantation of the lung are other choices. Prednisone A corticosteroid idiopathic pulmonary fibrosis, prednisone idiopathic pulmonary fibrosis, is the most common drug given to patients with idiopathic pulmonary fibrosis. About 25 to 35 percent of all patients respond favorably to this medicine. No one knows exactly how corticosteroids work or why some patients do well on prednisone while others do not. Patients take prednisone by mouth every morning idiopathic pulmonary fibrosis, starting with a high dose for the first 4 to 8 weeks. As they improve idiopathic pulmonary fibrosis, they gradually take smaller amounts. Changes in mood are one of the more common side effects of prednisone; most patients idiopathic pulmonary fibrosis, however idiopathic pulmonary fibrosis, can handle the mood changes -- anxiety idiopathic pulmonary fibrosis, depression idiopathic pulmonary fibrosis, or sleeplessness -- once they know what is causing th.
idiopathic pulmonary fibrosis 
idiopathic pulmonary fibrosis | | | | | |
idiopathic pulmonary fibrosis
fingertips may develop. The patient may also become less able to fight infection. In advanced stages of the illness, the patient may need oxygen all the time. IPF can lead to death. Often the immediate cause is respiratory failure due to hypoxemia, right-heart failure, a heart attack, blood clot (embolism) in the lungs, stroke, or lung infection brought on by the disease. What is the Course of IPF? Although the course of idiopathic pulmonary fibrosis varies greatly from person to person, the disease usually develops slowly, sometimes over years. The early stages are marked by alveolitis, an inflammation of the air sacs called alveoli, in the lungs. The job of the air sacs is to allow the transfer of oxygen from the lungs into the blood and the elimination of carbon dioxide from the lungs and out of the body. As IPF progresses, the alveoli become damaged and scarred, thus stiffening the lungs. The stiffening makes breathing difficult and brings on a feeling of breathlessness (dyspnea),
|
bravenet.com